Evidence map›Paper›PMID 18558641›Full record

Trial reportBMJ (Clinical research ed.)2008

Effect of 50,000 IU vitamin A given with BCG vaccine on mortality in infants in Guinea-Bissau: randomised placebo controlled trial.

Christine Stabell Benn, Birgitte Rode Diness, Adam Roth, Ernesto Nante, Ane Baerent Fisker, Ida Maria Lisse, Maria Yazdanbakhsh, Hilton Whittle, Amabelia Rodrigues, Peter Aaby

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ (Clinical research ed.), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00168597 (Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries?), which is not on this map. Cited by 53 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 9 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00168597 phase4completednot on this map

Should Infants Receive High-dose Vitamin A Supplementation With BCG Vaccine at Birth in Developing Countries?

TypeinterventionalSponsorBandim Health ProjectRan2002Enrolled4,800ConditionsMortality, MorbidityArmsVitamin A
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 9 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. The Effect of Oral Polio Vaccine at Birth on Infant Mortality: A Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 5 countries.

Christine Stabell BennBandim Health Project, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark. cb@ssi.dk
Birgitte Rode Diness
Adam Roth
Ernesto Nante
Ane Baerent Fisker
Ida Maria Lisse
Maria Yazdanbakhsh
Hilton Whittle
Amabelia Rodrigues
Peter Aaby
Bandim Health Project · GWStatens Serum Institut · DKHerlev Hospital · DKLeiden University · NLLund University · SEMRC Unit the Gambia · GM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the effect of high dose vitamin A supplementation given with BCG vaccine at birth in an African setting with high infant mortality.

designRandomised placebo controlled trial. Setting Bandim Health Project's demographic surveillance system in Guinea-Bissau, covering approximately 90,000 inhabitants. Participants 4345 infants due to receive BCG.

interventionInfants were randomised to 50,000 IU vitamin A or placebo and followed until age 12 months.

main outcome measureMortality rate ratios.

results174 children died during follow-up (mortality=47/1000 person-years). Vitamin A supplementation was not significantly associated with mortality; the mortality rate ratio was 1.07 (95% confidence interval 0.79 to 1.44). The effect was 1.00 (0.65 to 1.56) during the first four months and 1.13 (0.75 to 1.68) from 4 to 12 months of age. The mortality rate ratio in boys was 0.84 (0.55 to 1.27) compared with 1.39 (0.90 to 2.14) in girls (P for interaction=0.10). An explorative analysis revealed a strong interaction between vitamin A and season of administration.

conclusionsVitamin A supplementation given with BCG vaccine at birth had no significant benefit in this African setting. Although little doubt exists that vitamin A supplementation reduces mortality in older children, a global recommendation of supplementation for all newborn infants may not contribute to better survival.

trial registrationClinical trials NCT00168597.

Indexed as

Infant MortalityBCG VaccineCause of DeathFemaleGuinea-BissauHumansInfant, NewbornMaleSeasonsSex DistributionSurvival RateVitamin AVitaminsBCG VaccineVitamin AVitamins

Identifiers

PMID18558641
PMCPMC2432170
OpenAlexW2065256315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.